DNMT3A and leukemia: CHIP arises in older individuals due to leukaemia-associated mutations, primarily in epigenetic modifiers DNMT3A, TET2 and ASXL1, within haematopoietic stem cells (HSCs), leading to the emergence of pre-leukaemic cells.